Faga Daniel bought ANAB
January 6, 2026 · Form 4 insider transaction
Faga Daniel bought 17,850 shares of AnaptysBio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,850
Price
N/A
Total value
N/A
InsiderFaga Daniel
RoleOfficer, Director
CompanyAnaptysBio, Inc. (ANAB)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after475,989
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.